Cargando…
The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
This review is focused in PI3K’s involvement in two widespread mental disorders: Autism and Schizophrenia. A large body of evidence points to synaptic dysfunction as a cause of these diseases, either during the initial phases of brain synaptic circuit’s development or later modulating synaptic funct...
Autores principales: | Enriquez-Barreto, Lilian, Morales, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751644/ https://www.ncbi.nlm.nih.gov/pubmed/26877878 http://dx.doi.org/10.1186/s40591-016-0047-9 |
Ejemplares similares
-
Signaling Pathways and Sex Differential Processes in Autism Spectrum Disorder
por: Enriquez, Kristen D., et al.
Publicado: (2021) -
Learning improvement after PI3K activation correlates with de novo formation of functional small spines
por: Enriquez-Barreto, Lilian, et al.
Publicado: (2014) -
Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients
por: Stertz, Laura, et al.
Publicado: (2020) -
Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019) -
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)